Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$32.77 - $42.31 $13,108 - $16,924
400 Added 4.84%
8,668 $362,000
Q3 2023

Nov 14, 2023

SELL
$35.46 - $40.13 $3,723 - $4,213
-105 Reduced 1.25%
8,268 $311,000
Q2 2023

Aug 14, 2023

BUY
$24.24 - $40.97 $39,777 - $67,231
1,641 Added 24.38%
8,373 $317,000
Q4 2022

Feb 14, 2023

BUY
$27.6 - $32.99 $9,356 - $11,183
339 Added 5.3%
6,732 $195,000
Q3 2022

Nov 14, 2022

SELL
$28.74 - $39.9 $1,149 - $1,596
-40 Reduced 0.62%
6,393 $192,000
Q2 2022

Aug 22, 2022

SELL
$35.0 - $43.59 $17,150 - $21,359
-490 Reduced 7.08%
6,433 $233,000
Q1 2022

May 16, 2022

BUY
$43.12 - $50.3 $63,127 - $73,639
1,464 Added 26.82%
6,923 $299,000
Q4 2021

Feb 14, 2022

SELL
$47.6 - $65.0 $2,665 - $3,640
-56 Reduced 1.02%
5,459 $274,000
Q3 2021

Nov 15, 2021

BUY
$62.34 - $73.38 $3,117 - $3,669
50 Added 0.91%
5,515 $351,000
Q2 2021

Aug 12, 2021

SELL
$70.26 - $76.64 $3,864 - $4,215
-55 Reduced 1.0%
5,465 $394,000
Q1 2021

May 17, 2021

SELL
$70.48 - $79.95 $4,087 - $4,637
-58 Reduced 1.04%
5,520 $407,000
Q4 2020

Feb 12, 2021

BUY
$54.4 - $73.42 $34,489 - $46,548
634 Added 12.82%
5,578 $410,000
Q3 2020

Nov 13, 2020

SELL
$54.41 - $68.2 $489 - $613
-9 Reduced 0.18%
4,944 $271,000
Q4 2019

Feb 13, 2020

SELL
$74.18 - $97.92 $35,087 - $46,316
-473 Reduced 8.72%
4,953 $436,000
Q1 2019

May 15, 2019

BUY
$85.97 - $108.09 $42,641 - $53,612
496 Added 10.06%
5,426 $586,000
Q4 2018

Feb 15, 2019

BUY
$78.25 - $107.92 $145,701 - $200,947
1,862 Added 60.69%
4,930 $417,000
Q2 2018

Aug 10, 2018

SELL
$97.62 - $120.59 $34,459 - $42,568
-353 Reduced 10.32%
3,068 $355,000
Q1 2018

May 17, 2018

BUY
$95.91 - $107.26 $7,768 - $8,688
81 Added 2.43%
3,421 $338,000
Q4 2017

Feb 13, 2018

BUY
$104.5 - $126.38 $349,030 - $422,109
3,340
3,340 $350,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.